在住院治疗急性减补期间,是否可以安全地启动/优化HFrEF患者的药物治疗?
Ruxandra Maria Christodorescu1,2, Daniel Miron Brie2,3, Alina Diduța Brie4,5
1Department of Internal Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.
Journal of clinical medicine
|April 26, 2025
概括
在住院期间启动或优化心力衰竭的指导方针导向医疗疗,以减少喷射率 (HFrEF) 是可行的. 早期治疗改善了临床参数和功能状态,支持当前的建议.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 目前的指导方针建议在急性去补偿病例的住院期间开始或优化心力衰竭的四大支柱,以减少喷射分数 (HFrEF) 治疗.
- 这些支柱包括β-阻断剂 (BB),矿物质皮质类受体对抗剂 (MRA),血管新生素受体-尼普利辛抑制剂 (ARNI) 和-葡萄糖携带输送-2 抑制剂 (SGLT2i).
研究的目的:
- 这项研究旨在比较HFrEF患者的临床特征和结果,根据他们在住院期间是否刚开始或已经接受HFrEF治疗的四个支柱中的至少一个.
- 评估早期干预的可行性和影响.
主要方法:
- 一项前性观察性研究包括203名因急性不补偿而住院的HFrEF患者.
- 患者被分为两组:A组 (n=126) 在入院前没有接受任何支柱,B组 (n=77) 接受至少一个支柱.
- 评估了临床和生物参数,包括体重,血压,心率,功能,电解质和30天死亡率.
主要成果:
- 两组之间30天死亡率没有显著差异 (A组:7.14%,B组:5.55%,p=0.74).
- 两组都显示出血压,心率和NYHA功能类 (p<0.05) 的显著改善.
- B组的血清肌素增加更大 (p=0.02),而A组的喷射分数改善更为明显 (p=0.057).
结论:
- 在住院期间启动或优化HFrEF治疗的四个支柱是可行的,并且耐受良好.
- 早期干预可以改善临床参数和功能状态,与指南建议保持一致.
- 功能需要在治疗优化过程中仔细考虑.
关键词:
急性心力衰竭住院治疗 住院治疗没有补偿的心力衰竭.利尿剂是一种利尿剂.治疗的四个支柱是治疗的四个支柱.指南导向医学疗法 (GDMT) 是指南导向医学疗法.减少喷射率 (HFrEF) 的心力衰竭.血清过高的高卡利米亚.低血压是因为低血压.这是一种天然尿素.容量超负荷的体积超负荷更多相关视频
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
1.6K
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
30.3K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
305
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
305
01:22Heart Failure Drugs: Diuretics
282
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
282
01:11Renal Failure: Dose Adjustments
35
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
35
01:22Heart Failure Drugs: β-Blockers
260
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
260
01:26Heart Failure Drugs: Inotropic Agents
405
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
405
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
31
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
31